Biogen’s Good News Could Be Great News For Other Biotechs Focused On Neurodegenerative Diseases
The FDA’s approval of Biogen’s Alzheimer’s drug “has set a precedent, showing a much easier path to approval for investigative drug treatments focused on neurodegenerative…